Chiral Posted December 1, 2009 Randox Laboratories last week launched several multi-marker drugs-of-abuse testing arrays. The biochips enable the analysis of up to 10 drug classes from a single patient sample. Two drugs-of-abuse arrays are available: DoA array I contains markers for amphetamine, methamphetamine, barbituates, benzodiazepine 1 & 2, cannabinoids, cocaine metabolite, methadone, opiates, and phencyclidine; DoA array II enables testing for buprenorphine, fentanyl, generic opioids, ketamine, LSD, MDMA, methaqualone, oxycodone 1 & 2, and propoxyphene. Creatinine is also included on the arrays as a marker of adulteration when testing urine samples. Both arrays are validated for use with urine and whole blood. The biochips are designed for use with Randox's line of Evidence instruments. SOURCE Share this post Link to post Share on other sites
